Relationship between mean platelet volume elevation and left ventricular mass index in hypertensive patients

Mustafa Ferzeyn Yavuzkir1, Ertuğrul Kurtoğlu2, Mücahid Yilmaz2

  • 1Department of Cardiology, School of Medicine, Firat University, Elazig, Turkey ferzeyn@hotmail.com.

Insights

Patients with untreated hypertension exhibit higher mean platelet volume (MPV), a marker of platelet activation. However, this elevated MPV did not correlate with left ventricular mass index (LVMI) in hypertensive individuals.

Area of Science:

  • Cardiology
  • Hematology
  • Hypertension Research

Background:

  • Mean platelet volume (MPV) serves as a general indicator of platelet activation.
  • Hypertension is associated with cardiovascular changes, including left ventricular hypertrophy.
  • The relationship between platelet activation markers and cardiac remodeling in hypertension requires further investigation.

Purpose of the Study:

  • To compare MPV in patients with and without hypertension.
  • To investigate the association between MPV and left ventricular mass index (LVMI) in hypertensive patients.

Main Methods:

  • Cross-sectional, observational study design.
  • Inclusion of newly diagnosed, untreated stage I-II hypertensive patients and healthy controls.
  • Measurement of MPV via automated hematology analyzer and LVMI via echocardiography.

Main Results:

  • Significantly higher MPV observed in the hypertensive group (10.3 ± 1.4 fl) compared to controls (9.2 ± 1.8 fl).
  • Significantly higher LVMI observed in the hypertensive group (115.9 ± 23.0 g/m²) compared to controls (95.7 ± 23.4 g/m²).
  • No significant correlation found between MPV and LVMI in the study population.

Conclusions:

  • Elevated MPV is present in patients with untreated hypertension.
  • Despite elevated MPV and LVMI in hypertensive patients, no direct correlation was established between these two parameters.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K